Sign In
Buy ECOR
$6.09
-0.205 (-3.26%)
At Close: Jul 31, 2026
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
08:15pm, Wednesday, 13'th Mar 2024
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
06:26pm, Wednesday, 13'th Mar 2024
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $1.22 per share a year ago.
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 13'th Mar 2024
Record full year 2023 net sales of $ 16.0 million increased 87% over $8.6 million for the full year 2022
electroCore to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 12'th Mar 2024
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company's Chief Strategy O
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
04:05pm, Tuesday, 05'th Mar 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial resu
electroCore Expands Intellectual Property Portfolio
08:00am, Tuesday, 06'th Feb 2024
ROCKAWAY, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Tradema
electroCore Expands Intellectual Property Portfolio
08:00am, Tuesday, 09'th Jan 2024
ROCKAWAY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Tradema
electroCore Expands Intellectual Property Portfolio
08:00am, Tuesday, 26'th Dec 2023
ROCKAWAY, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue no
electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology
08:00am, Tuesday, 12'th Dec 2023
ROCKAWAY, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Tradema
ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company's Chief Medical Off
electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript
10:27pm, Wednesday, 08'th Nov 2023
electroCore, Inc. (NASDAQ:ECOR ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer C
electroCore to Announce Third Quarter Financial Results on Wednesday, November 8
08:00am, Monday, 09'th Oct 2023
ROCKAWAY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial resul
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
08:00am, Thursday, 05'th Oct 2023
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, wi
electroCore to Present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference
08:00am, Thursday, 21'st Sep 2023
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, w
electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript
10:14pm, Wednesday, 09'th Aug 2023
electroCore, Inc. (NASDAQ:ECOR ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Daniel Goldberger - CEO & Director Brian Posner - CFO & Corporate Secretary Conference
